CYTEK BIOSCIENCES, INC. (CTKB) Shareholders’ equity 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) shareholders’ equity at each fiscal year-end, per SEC filings.
$341.7MFY2025 · since FY2020: -$16.0M → $341.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $341.7M | -13.6% |
| FY2024 | $395.7M | +0.7% |
| FY2023 | $393.1M | -7.6% |
| FY2022 | $425.5M | +5.0% |
| FY2021 | $405.4M | +2629.2% |
| FY2020 | -$16.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice